We are live on
!
Find out more
VanEck Pharmaceutical ETF
PPH
PPH
147 hedge funds and large institutions have $789M invested in VanEck Pharmaceutical ETF in 2026 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 41 increasing their positions, 42 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
22% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 23
1% more funds holding
Funds holding: 146 → 147 (+1)
2% less capital invested
Capital invested by funds: $806M → $789M (-$17.3M)
2% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 42
7.8% less ownership
Funds ownership: 68.62% → 60.82% (-7.8%)
95% less call options, than puts
Call options by funds: $603K | Put options by funds: $11M
Holders
147
Holders Change
+1
Holders Change %
+0.68%
% of All Funds
1.81%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.02%
New
28
Increased
41
Reduced
42
Closed
23
Calls
$603K
Puts
$11M
Net Calls
-$10.4M
Net Calls Change
-$12.6M
Top Buyers
| 1 |
Jane Street
New York
|
+$86.4M |
| 2 |
ERSOT
Employees Retirement System of Texas
Austin,
Texas
|
+$56.6M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$34.4M |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$31.5M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$26.5M |
